🎗️
Our breast cancer program integrates molecular subtyping, targeted therapy trials, and survivorship research to improve outcomes across all stages of disease.
Learn MoreWhole-exome and RNA sequencing to identify actionable mutations and resistance mechanisms in TNBC prevalent in South Asian populations.
Evaluating checkpoint inhibitors combined with PARP inhibitors and novel antibody-drug conjugates for advanced disease.
AI-powered mammography interpretation and community health worker–led screening programs in rural Tamil Nadu.
Prospective studies on long-term cardiotoxicity, lymphedema management, and integrative oncology interventions.
NCT06234501
RecruitingPI: Dr. Rama Jayaraj
NCT06234502
ActivePI: Dr. Shirley Sunder Singh
NCT06234503
RecruitingPI: Dr. Arvind Krishnamurthy
Your contribution funds cutting-edge clinical trials and early detection programs that directly improve survival for thousands of women each year.
Donate Now
.png&w=96&q=75){kind=small}